JSA advised Serum Institute of India Private Limited (“Serum”), in its sale of 35% stake in Schott Poonawalla Private Limited (“Schott Poonawalla”) to TPG Scion Unit Trust (acting through its trustee Scion Trustee Limited) (“TPG”). Schott Poonawalla is a joint venture between Serum and the Schott group — pursuant to the proposed sale, the Schott group remains a majority shareholder in Schott Poonawalla, while Serum and TPG will hold 15.01% and 34.99%, respectively. The transaction was subject to CCI approval, which was successfully received last month. JSA was assisted by Gibson, Dunn & Crutcher LLP on the anti-bribery and anti-corruption-related aspects of the transaction.<\/p>\n
SCHOTT Poonawalla is India’s largest injectables-focused drug containment solutions company, offering a comprehensive product portfolio of the highest quality for over two decades.<\/p>\n
JSA transaction team comprised Lead Partner & National Corporate Lead, Iqbal Khan, Partner, Devika Menon, Senior Associate, Subbalaxmi S and Associate, Gunjan Singh.<\/p>\n
JSA competition team comprised Partner and Chair, Competition Law, Nisha Kaur Uberoi, Principal Associate, Rahat Dhawan, Senior Associate, Rishi Kauntia and Associate, Cherian Chacko Manayath.<\/p>\n","protected":false},"excerpt":{"rendered":"
JSA advised Serum Institute of India Private Limited (\u201cSerum\u201d)<\/i><\/p>\n","protected":false},"author":67011,"featured_media":347380,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[45282,2],"tags":[81821,50808,81364,46117,59358,81819,81818,81820],"class_list":["post-347377","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-law-firms-news","category-news","tag-investment-transaction","tag-jsa","tag-legal-advisory","tag-private-equity","tag-sale-of-stake","tag-schott-poonawalla","tag-serum-institute-of-india","tag-tpg-scion-unit-trust"],"yoast_head":"\n